| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000021486 |
| Receipt No. | R000024687 |
| Scientific Title | The contributing factors to the responsiveness of inhaled corticosteroids in patients with untreated asthma |
| Date of disclosure of the study information | 2016/03/17 |
| Last modified on | 2020/05/06 (Ver. 8) |
| Basic information | ||
| Public title | The contributing factors to the responsiveness of inhaled corticosteroids in patients with untreated asthma | |
| Acronym | The contributing factors to the responsiveness of inhaled corticosteroids in patients with untreated asthma | |
| Scientific Title | The contributing factors to the responsiveness of inhaled corticosteroids in patients with untreated asthma | |
| Scientific Title:Acronym | The contributing factors to the responsiveness of inhaled corticosteroids in patients with untreated asthma | |
| Region |
|
|
| Condition | ||
| Condition | asthma | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To identify some contributing factors to the responsiveness of inhaled corticosteroids in patients with untreated asthma |
| Basic objectives2 | Others |
| Basic objectives -Others | To identify some contributing factors to the responsiveness of inhaled corticosteroids in patients with untreated asthma |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | To identify some contributing factors to the amount of changes of forced expiratory volume in 1 second (FEV1) or FEV1 predicted normal (%FEV1) |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patient with asthma who have not received inhaled cotrticosteroids at the time of diagnosis, and taken pulmonary function test at about 6 months and 1 year after diagnosis. | |||
| Key exclusion criteria | If patients meet the following criteria, they are excluded.
Patients who have already received inhaled corticosteroids. have restrictive lung diseases such as intestitial lung disease or diffuse pleural thickening. have severe bronchiectasis. have primary lung cancer, metastatic lung cancer, or pulmonary invasion of hematologic tumor have surgical history of lung including partial resection |
|||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nagoya City University | ||||||
| Division name | Dept of Respiratory Medicine, Allergy and Clinical Immunology | ||||||
| Zip code | 4678601 | ||||||
| Address | 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, Japan | ||||||
| TEL | 052-853-8216 | ||||||
| kaney32@med.nagoya-cu.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nagoya City University | ||||||
| Division name | Dept of Respiratory Medicine, Allergy and Clinical Immunology | ||||||
| Zip code | 4678601 | ||||||
| Address | 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, Japan | ||||||
| TEL | 052-853-8216 | ||||||
| Homepage URL | |||||||
| k-fkmt@med.nagoya-cu.ac.jp | |||||||
| Sponsor | |
| Institute | Nagoya City University Dept of Respiratory Medicine, Allergy and Clinical Immunology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Nagoya City University Dept of Respiratory Medicine, Allergy and Clinical Immunology |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Daidou hospital and daidou clinic |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Clinical research management center, Nagoya City University Hospital |
| Address | 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, Japan |
| Tel | 052-851-5511 |
| clinical_research@med.nagoya-cu.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 名古屋市立大学病院(愛知県)、大同病院・だいどうクリニック(愛知県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | ||
| URL related to results and publications | ||
| Number of participants that the trial has enrolled | 13 | |
| Results | ||
| Results date posted | ||
| Results Delayed |
|
|
| Results Delay Reason | We could not analyze because of small samples. We have already submitted a new research plan using optout to institutional review board of our university. | |
| Date of the first journal publication of results | ||
| Baseline Characteristics | Patients who were diagnosed asthma first time and did not receive treatments for asthma at the diagnosis. |
|
| Participant flow | Patients who were steroid-naive asthma at the first visit and took pulmonary function test at 6 and 12 months after treatments intervention were enrolled. |
|
| Adverse events | Nothing. |
|
| Outcome measures | Factors contributing to changes in pulmonary function. |
|
| Plan to share IPD | ||
| IPD sharing Plan description | ||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Design
retrospective study Enrollment Patients who met the criteria of this study will be enrolled between March 2016 and March 2018. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024687 |